CFAR Microgrant Program
The goal of funding by
CFAR microgrants to rapidly respond to the needs of CFAR investigators or
Einstein investigators interested in expanding into HIV/AIDS research by supporting
highly focused and goal-driven experiments designed to achieve small but
practical end points to help generate data needed to submit or revise a manuscript
or to submit a CFAR pilot grant or externally-funded grant. Examples of
appropriate use of this funding mechanism is to purchase critical reagents
needed for experiments or to support the use of CFAR or Einstein Cores. The maximum
amount of funding provided is $5,000 and is non-renewable. Applications can be submitted to Dr. Prasad by
anyone at any time and consist of a one page description of the proposed
experiment describing how the proposed work would rapidly lead to publication
or grant application, a budget justification and a NIH CV of the applicant and
relevant personnel. Applications are rapidly reviewed by a standing committee
chaired by Dr. Vinayaka Prasad, Developmental Core Director and Associate
Director and the CFAR Director and CFAR Associate Director.
Einstein-Montefiore CFAR Pilot Project Funding Opportunity Announcement:
pilot projects- April 30, 2013- For further information, click here.
Centralized listing of all Pilot Grants available to Einstein investigators
A web page listing of all active Center, Institute and Department Pilot Grants currently open for applications with deadlines and further information can be viewed here (https://www.einstein.yu.edu/research/pilot-grants)
The 2013 Burroughs Wellcome Fund for Investigators in Pathogenesis of Infectious Diseases Program
Einstein may nominate two candidates for the opportunity to receive $500,000 in 5 years and "give recipients the freedom and flexibility to pursue high-risk projects and new avenues of inquiry. Work supported will be efforts that have the potential to significantly advance the understanding of how microbes and the human system interact, especially in the context of infection. Biochemical, pharmacological, molecular, genetic, immunologic, and other approaches are all appropriate for support by the program."
Areas of particular interest include:
Cell/Pathogen interactions—studies of host responses at the cell surface, cell signaling in response to infection, microbial persistence in host cells, and other work.
Host/Pathogen interactions—studies of how host genetics influences resistance and susceptibility to infection, innate and adaptive immune responses to microbes, pathogen modulation of the immune system, and other work.
Novel routes to disease causation—studies of the role of infectious agents in the etiology of chronic, autoimmune, and immunologic diseases, and other work.
PA-12-281: HIV/AIDS, Drug Use, and Vulnerable Populations in the US
NIDA has issues a PA on the intersection of substance abuse and HIV infection. Despite progress in HIV/AIDS treatment and prevention and reductions in HIV/morbidity and mortality, HIV/AIDS health disparities remain a challenge that must be addressed. This FOA encourages research to identify the role(s) that drug abuse plays in fueling the epidemic in vulnerable groups (racial/ethnic minorities, men who have sex with men (MSM), youth) in the United States and to develop effective interventions to prevent new infections and to improve the health and well-being of those living with HIV/AIDS. This FOA will support studies in vulnerable populations to: 1) understand the contribution of drug abuse (both injection and non-injection) to the acquisition and/or transmission of HIV; 2) study disease progression and disease outcomes; 3) develop and/or improve prevention and treatment interventions, particularly comprehensive, integrated interventions; 4) improve the availability, delivery and quality of evidence-based prevention and treatment services across a variety of settings; and 5) address organizational, structural, and/or community level factors including social, drug-using, and sexual networks associated with health disparities. For further information go to: http://grants.nih.gov/grants/guide/pa-files/PA-12-281.html